AnaptysBio Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015
Cash & Equivalents	35.97	71.31	495.73	250.46	171.08	113.66	81.25	51.29	51.74
Short-Term Investments	354.94	369.93	52.37	143.2	203.21	313.49	167.22	0	0
Cash & Cash Equivalents	390.9	441.24	548.1	393.65	374.29	427.14	248.47	51.29	51.74
Cash Growth	-11.41%	-19.50%	39.23%	5.17%	-12.37%	71.91%	384.42%	-0.87%	-
Receivables	6.85	1.42	0.88	0	0	0	0	1.23	1.23
Other Current Assets	9.08	4.55	4.9	2.91	3.45	7.07	4.23	5.69	0.49
Total Current Assets	406.84	447.21	553.88	396.56	377.73	434.22	252.7	58.21	53.46
Property, Plant & Equipment	18.27	19.99	21.84	2.13	1.62	1.45	0.67	0.47	0.55
Long-Term Investments	27.03	142.94	67.1	17.61	54.31	73.13	75.9	0	0
Other Long-Term Assets	0.26	0.26	0.26	0.26	1.54	0.21	0.11	3.5	2.27
Total Long-Term Assets	45.55	163.18	89.19	19.99	57.46	74.78	76.67	3.97	2.82
Total Assets	452.39	610.38	643.07	416.55	435.2	509	329.36	62.18	56.28
Accounts Payable	4.7	2.78	1.74	4.22	16.24	5.44	2.32	2.28	1.52
Deferred Revenue	0	0	0	0	0	0	0	0	2.94
Current Debt	1.78	1.64	1.51	0.34	1.38	7.57	6.88	0	0
Other Current Liabilities	30.97	21.63	12.85	15.26	11.92	8.82	4.89	3.43	2.91
Total Current Liabilities	37.44	26.05	16.1	19.82	29.54	21.84	14.09	5.71	7.38
Long-Term Debt	16.04	17.81	19.45	0	0	0	7.55	13.81	4.9
Other Long-Term Liabilities	310.81	304.41	251.09	0	0.65	0.8	0.14	80.91	79.18
Total Long-Term Liabilities	326.84	322.23	270.54	0	0.65	0.8	7.69	94.72	84.08
Total Liabilities	364.29	348.28	286.64	19.82	30.19	22.63	21.78	100.43	91.46
Total Debt	17.81	19.45	20.96	0.34	1.38	7.57	14.43	13.81	4.9
Debt Growth	-8.41%	-7.18%	6027.19%	-75.13%	-81.85%	-47.50%	4.48%	181.64%	-
Retained Earnings	-614.1	-450.48	-321.75	-263.96	-244.03	-146.69	-85.03	-54.92	-50.66
Comprehensive Income	-0.8	-5.25	-0.42	-0	0.34	-0.22	-0.43	0	0
Shareholders' Equity	88.1	262.1	356.43	396.73	405.01	486.37	307.58	-38.25	-35.18
Net Cash / Debt	373.09	421.79	527.14	393.31	372.91	419.57	234.04	37.48	46.84
Net Cash / Debt Growth	-11.55%	-19.99%	34.03%	5.47%	-11.12%	79.27%	524.39%	-19.98%	-
Net Cash Per Share	13.86	14.98	19.22	14.41	13.78	17.01	11.83	14.21	18.36
Working Capital	369.39	421.15	537.78	376.74	348.2	412.38	238.61	52.5	46.09
Book Value Per Share	3.27	9.31	12.99	14.53	14.97	19.71	15.55	-14.50	-13.79

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).